Diagnostic value of Xpert
bladder cancer
cystoscopy
follow-up
urinary markers
Journal
Therapeutic advances in urology
ISSN: 1756-2872
Titre abrégé: Ther Adv Urol
Pays: England
ID NLM: 101487328
Informations de publication
Date de publication:
Historique:
received:
18
01
2021
accepted:
27
01
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
23
3
2021
Statut:
epublish
Résumé
Xpert We conducted a prospective study on 1015 samples of 416 patients (mean age 72.2 ± 10.3 years) under follow-up for NMIBC. Patients underwent voided urinary cytology, the Xpert We identified 168 recurrent tumours: 126 (75%) were low-grade (LG) and 42 (25%) high-grade (HG). Overall sensitivity was 17.9% for cytology, 52.4% for Xpert Our data confirm a significantly higher sensitivity of Xpert
Identifiants
pubmed: 33747133
doi: 10.1177/1756287221997183
pii: 10.1177_1756287221997183
pmc: PMC7940738
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1756287221997183Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declare that there is no conflict of interest.
Références
Cancer Cytopathol. 2020 May;128(5):341-347
pubmed: 31977131
Eur Urol. 2017 Mar;71(3):447-461
pubmed: 27324428
Eur Urol. 2014 Aug;66(2):253-62
pubmed: 24472711
Curr Opin Urol. 2014 Sep;24(5):487-91
pubmed: 24887047
BJU Int. 2018 Jan;121(1):29-37
pubmed: 28941000
J Urol. 2018 Mar;199(3):655-662
pubmed: 29061538
Eur Urol. 2019 May;75(5):853-860
pubmed: 30553612
Perspect Clin Res. 2018 Jan-Mar;9(1):40-43
pubmed: 29430417
World J Urol. 2019 Oct;37(10):2059-2065
pubmed: 30446799
Clin Cancer Res. 2010 May 1;16(9):2624-33
pubmed: 20406841
Qual Life Res. 2016 Sep;25(9):2307-14
pubmed: 26984467
J Clin Pathol. 2019 Feb;72(2):140-144
pubmed: 30355587
Am J Surg Pathol. 1998 Dec;22(12):1435-48
pubmed: 9850170